Brian Olsavsky
Director of Finance/CFO at AMAZON.COM, INC.
Net worth: 12 M $ as of 2025-01-30
Profile
Brian T. Olsavsky holds the position of Chief Financial Officer & Senior Vice President of Amazon.com, Inc. In the past he occupied the position of Assistant Vice President at Deutsche Morgan Grenfell. Mr. Olsavsky received an undergraduate degree from The Pennsylvania State University and an MBA from Carnegie Mellon University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-11-20 | 50,562 ( 0% ) | 12 M $ | 2025-01-30 |
Latest news about Brian Olsavsky
Brian Olsavsky active positions
Companies | Position | Start |
---|---|---|
AMAZON.COM, INC. | Director of Finance/CFO | 2015-05-31 |
Former positions of Brian Olsavsky
Companies | Position | End |
---|---|---|
Deutsche Morgan Grenfell | Corporate Officer/Principal | - |
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Director/Board Member | - |
Training of Brian Olsavsky
The Pennsylvania State University | Undergraduate Degree |
Carnegie Mellon University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AMAZON.COM, INC. | Retail Trade |
Private companies | 2 |
---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Deutsche Morgan Grenfell | Finance |
- Stock Market
- Insiders
- Brian Olsavsky